<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The erythropoietin-analogue darbepoetin-α (DPO) improves liver function and regeneration after hepatectomy (Phx), however, also enhances Phx-induced <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell engraftment and neovascularization </plain></SENT>
<SENT sid="1" pm="."><plain>Because it is unknown whether DPO also enhances the growth of established <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, we herein studied the effect of DPO on established colorectal <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> after Phx </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: CT26.WT cells were implanted into the liver of BALB/c mice </plain></SENT>
<SENT sid="3" pm="."><plain>Five days after <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> establishment, animals underwent 50% Phx and received 10 μg/kgBW DPO or saline </plain></SENT>
<SENT sid="4" pm="."><plain>Non-Phx animals with DPO or saline-treatment served as controls </plain></SENT>
<SENT sid="5" pm="."><plain>Seven days after Phx <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> were analyzed regarding blood vessel formation, leukocyte <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e>, cell proliferation, apoptotic cell <z:hpo ids='HP_0011420'>death</z:hpo>, and growth using intravital fluorescence microscopy, histology, and immunohistochemistry </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: The growth of established colorectal <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> was slightly stimulated after DPO-treatment in hepatectomized and non-hepatectomized animals </plain></SENT>
<SENT sid="7" pm="."><plain>However, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> vessel formation and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell proliferation were significantly enhanced after DPO-treatment in hepatectomized and non-hepatectomized mice compared with controls </plain></SENT>
<SENT sid="8" pm="."><plain>Apoptotic cell <z:hpo ids='HP_0011420'>death</z:hpo> and leukocyte-endothelial cell interaction were significantly reduced after DPO-treatment </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Our study indicates that DPO-treatment promotes neovascularization and cell proliferation in established colorectal <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> of hepatectomized and non-hepatectomized mice </plain></SENT>
<SENT sid="10" pm="."><plain>DPO-application in patients with colorectal <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> might promote <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e> and should therefore be avoided </plain></SENT>
</text></document>